Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach.
Saved in:
| Title: | Repurposing mitochondrial-targeting drugs for management of ICANS in CAR T-cell therapy: a novel steroid-sparing approach. |
|---|---|
| Authors: | Zahedi A; Department of Clinical Pharmacy Practice, University of California Irvine, Irvine, CA, United States.; Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA, United States., Ifejeokwu OV; Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA, United States., Griffin SP; Department of Clinical Pharmacy Practice, University of California Irvine, Irvine, CA, United States.; Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, United States., Dean EA; Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Jul 28; Vol. 17, pp. 1896516. Date of Electronic Publication: 2026 Jul 28 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1896516 |
